Lecanemab-irmb Injection Drug Interactions
- Leqembi
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
About Lecanemab-irmb Injection
Lecanemab-irmb injection is used to treat Alzheimer's disease (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in patients with mild disease. Lecanemab-irmb is in a class of medications called monoclonal antibodies.
Read the full Lecanemab-irmb Injection drug information pageQuick links
The Bottom Line on Lecanemab-irmb Injection
Bleeding is the problem that comes up most with lecanemab-irmb, and with this medicine it can mean swelling or bleeding in the brain. It is given by injection to people with mild Alzheimer's disease, to help with the memory and thinking problems the illness causes.
There is a lot to keep track of here. It has more documented interactions than most medicines, and most of them are rated major. The ones that stand out are the blood thinners apixaban, rivaroxaban and warfarin, each rated major because of a higher chance of brain swelling or bleeding. So tell every prescriber, a dentist or an urgent care clinic included, that you take lecanemab-irmb before anything new is started.
From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy
Check Lecanemab-irmb Injection Against Another Drug or Supplement
Type a drug, a brand name or a supplement. We check it against every documented lecanemab-irmb injection interaction, supplements and herbs included.
What Could Happen When Lecanemab-irmb Injection Interacts
What the 51 documented lecanemab-irmb injection interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.
This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site.
Lecanemab-irmb Injection Interactions by Severity
Major
- Lecanemab-irmb Injection and Acenocoumarol Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Alteplase, Recombinant Explained Brand name: Activase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Anistreplase Explained An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Apixaban Explained Brand names: Eliquis, ELIQUIS 30-Day Starter Pack, Eliquis Sprinkle An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Ardeparin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Argatroban Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Bemiparin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Betrixaban Explained Brand name: Bevyxxa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Bivalirudin Explained Brand name: Angiomax An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Certoparin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Dabigatran Etexilate Explained Brand name: Pradaxa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Dalteparin Explained Brand name: Fragmin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Danaparoid Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Desirudin Explained Brand name: Iprivask An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Edoxaban Explained Brand name: Savaysa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Enoxaparin Explained Brand name: Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Fondaparinux Explained Brand name: Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Heparin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Lepirudin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
- Lecanemab-irmb Injection and Nadroparin Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details
Look Up Another Drug
Still Have Questions About Lecanemab-irmb Injection?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
The References Behind Lecanemab-irmb Injection’s Interactions
The 14 sources our lecanemab-irmb injection interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →
- Product Information: LEQEMBI® intravenous injection, lecanemab-irmb intravenous injection. Eisai Inc (per FDA), Nutley, NJ, 2025. DailyMed
- Product Information: LEQEMBI IQLIK® intravenous injection, subcutaneous injection, lecanemab-irmb intravenous injection, subcutaneous injection. Eisai Inc, Nutley, NJ, 2026.
- Product Information: LEQEMBI(R) intravenous injection, lecanemab-irmb intravenous injection. Eisai Inc (per FDA), Nutley, NJ, 2023. DailyMed
- van Dyck CH, Swanson CJ, Aisen P, et al: Lecanemab in early Alzheimer's disease. N Engl J Med 2023; 388(1):9-21. PubMed
- Product Information: LEQEMBI(TM) intravenous injection, lecanemab-irmb intravenous injection. Eisai Inc (per manufacturer), Nutley, NJ, 2023. DailyMed
- McDade E, Cummings JL, Dhadda S, et al: Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study. Alzheimers Res Ther 2022; 14(1):191. PubMed
- Product Information: LEQEMBI(R) intravenous injection, lecanemab-irmb intravenous injection. Eisai Inc (per FDA), Nutley, NJ, 2024. DailyMed
- Product Information: LEQEMBI® IQLIK™ intravenous injection, subcutaneous injection, lecanemab-irmb intravenous injection, subcutaneous injection. Eisai Inc (per FDA), Nutley, NJ, 2025.
- Cummings J, Apostolova L, Rabinovici GD, et al: Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis 2023; 10(3):362-377. PubMed
- Product Information: CAMCEVI® subcutaneous emulsion, leuprolide subcutaneous emulsion. Accord Biopharma (per FDA), Raleigh, NC, 2025. DailyMed